Systemic sclerosis and vaccinations: a three-year register-based cohort study about vaccination rate and uptake from Liguria referral center, northwest Italy

References

• van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013 Nov;72(11):1747–6. PMID: 24092682. doi:10.1136/annrheumdis-2013-204424.
   PubMed Web of Science ®Google Scholar
• Elhai M, Avouac J, Walker UA, Matucci-Cerinic M, Riemekasten G, Airò P, Hachulla E, Valentini G, Carreira PE, Cozzi F, et al. A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study. Ann Rheum Dis. 2016 Jan;75(1):163–69. Epub 2014 Oct 23. PMID: 25342760. doi:10.1136/annrheumdis-2014-206386.
   PubMed Web of Science ®Google Scholar
• Thompson AE, Pope JE. Increased prevalence of scleroderma in southwestern Ontario: a cluster analysis. J Rheumatol. 2002 Sep;29(9):1867–73. PMID: 12233880.
   PubMed Web of Science ®Google Scholar
• Gazi H, Pope JE, Clements P, Medsger TA, Martin RW, Merkel PA, Kahaleh B, Wollheim FA, Baron M, Csuka ME, et al. Outcome measurements in scleroderma: results from a delphi exercise. J Rheumatol. 2007 Mar;34(3):501–09. Epub 2007 Feb 1. PMID: 17299843.
   PubMed Web of Science ®Google Scholar
• Filaci G, Fravega M, Negrini S, Procopio F, Fenoglio D, Rizzi M, Brenci S, Contini P, Olive D, Ghio M, et al. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function. Hum Immunol. 2004 Feb;65(2):142–56. PMID: 14969769. doi:10.1016/j.humimm.2003.12.001.
   PubMed Web of Science ®Google Scholar
• Manetti M, Pratesi S, Romano E, Bellando-Randone S, Rosa I, Guiducci S, Fioretto BS, Ibba-Manneschi L, Maggi E, Matucci-Cerinic M. Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis. PLoS One. 2017 Aug 10;12(8):e0183102. PMID: 28797111; PMCID: PMC5552290. doi:10.1371/journal.pone.0183102.
   PubMed Web of Science ®Google Scholar
• Pène F, Hissem T, Bérezné A, Allanore Y, Geri G, Charpentier J, Avouac J, Guillevin L, Cariou A, Chiche JD, et al. Outcome of patients with systemic sclerosis in the intensive care unit. J Rheumatol. 2015 Aug;42(8):1406–12. Epub 2015 Jul 1. PMID: 26136487. doi:10.3899/jrheum.141617.
   PubMed Web of Science ®Google Scholar
• Rubio-Rivas M, Royo C, Simeón CP, Corbella X, Fonollosa V. Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum. 2014 Oct;44(2):208–19. Epub 2014 May 14. PMID: 24931517. doi:10.1016/j.semarthrit.2014.05.010.
   PubMed Web of Science ®Google Scholar
• Chaisson NF, Hassoun PM. Systemic sclerosis-associated pulmonary arterial hypertension. Chest. 2013 Oct;144(4):1346–56. PMID: 24081346; PMCID: PMC3787920. doi:10.1378/chest.12-2396.
   PubMed Web of Science ®Google Scholar
• Nikpour M, Baron M. Mortality in systemic sclerosis: lessons learned from population-based and observational cohort studies. Curr Opin Rheumatol. 2014 Mar;26(2):131–37. PMID: 24441644. doi:10.1097/BOR.0000000000000027.
   PubMed Web of Science ®Google Scholar
• Murdaca G, Colombo BM, Cagnati P, Gulli R, Spanò F, Puppo F. Endothelial dysfunction in rheumatic autoimmune diseases. Atherosclerosis. 2012 Oct;224(2):309–17. Epub 2012 May 18. PMID: 22673743. doi:10.1016/j.atherosclerosis.2012.05.013.
   PubMed Web of Science ®Google Scholar
• Landemaine A, Petitcollin A, Brochard C, Miard C, Dewitte M, Le Balc’h E, Grainville T, Bellissant E, Siproudhis L, Bouguen G. Cumulative exposure to infliximab, but not trough concentrations, correlates with rate of infection. Clin Gastroenterol Hepatol. 2021 Feb;19(2):288–295.e4. Epub 2020 Mar 19. PMID: 32200087. doi:10.1016/j.cgh.2020.03.018.
   PubMed Web of Science ®Google Scholar
• Murdaca G, Spanò F, Contatore M, Guastalla A, Penza E, Magnani O, Puppo F. Infection risk associated with anti-TNF-α agents: a review. Expert Opin Drug Saf. 2015 Apr;14(4):571–82. Epub 2015 Jan 29. PMID: 25630559. doi:10.1517/14740338.2015.1009036.
   PubMed Web of Science ®Google Scholar
• Murdaca G, Spanò F, Contatore M, Guastalla A, Magnani O, Puppo F. Efficacy and safety of etanercept in chronic immune-mediated disease. Expert Opin Drug Saf. 2014;13(5):649–61. doi:10.1517/14740338.2014.899579.
   PubMed Web of Science ®Google Scholar
• Almaaitah S, Highland KB, Tonelli AR. Management of pulmonary arterial hypertension in patients with systemic sclerosis. Integr Blood Press Control. 2020 Mar 23;13:15–29. PMID: 32280271; PMCID: PMC7125406. doi:10.2147/IBPC.S232038.
   PubMed Web of Science ®Google Scholar
• Papadopoulos CG, Gartzonikas IK, Pappa TK, Markatseli TE, Migkos MP, Voulgari PV, Drosos AA. Eight-year survival study of first-line tumour necrosis factor α inhibitors in rheumatoid arthritis: real-world data from a university centre registry. Rheumatol Adv Pract. 2019 Mar 14;3(1):rkz007. PMID: 31431995; PMCID: PMC6649942. doi:10.1093/rap/rkz007.
   PubMedGoogle Scholar
• Rondaan C, Furer V, Heijstek MW, Agmon-Levin N, Bijl M, Breedveld FC, D’Amelio R, Dougados M, Kapetanovic MC, van Laar JM, et al. Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations. RMD Open. 2019;5(2):e001035. PMID: 31565247; PMCID: PMC6744079. doi:10.1136/rmdopen-2019-001035.
   PubMed Web of Science ®Google Scholar
• Aguilar-Guisado M, Jiménez-Jambrina M, Espigado I, Rovira M, Martino R, Oriol A, Borrell N, Ruiz I, Martín-Dávila P, de La Cámara R, et al. Spanish network for research in infectious diseases. Pneumonia in allogeneic stem cell transplantation recipients: a multicenter prospective study. Clin Transplant. 2011 Nov-Dec;25(6):E629–38. Epub 2011 Aug 21. PMID: 22150886. doi:10.1111/j.1399-0012.2011.01495.x.
   PubMed Web of Science ®Google Scholar
• Ghebrehewet S, MacPherson P, Ho A. Influenza. BMJ. 2016;355:1733–45.
   Google Scholar
• Hak E, Nordin J, Wei F, Mullooly J, Poblete S, Strikas R, Nichol KL. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clin Infect Dis. 2002 Aug 15;35(4):370–77. Epub 2002 Jul 19. PMID: 12145718. doi:10.1086/341403.
   PubMed Web of Science ®Google Scholar
• Blumentals WA, Arreglado A, Napalkov P, Toovey S. Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study. BMC Musculoskelet Disord. 2012 Aug 27;13(1):158. PMID: 22925480; PMCID: PMC3495205. doi:10.1186/1471-2474-13-158.
   PubMedGoogle Scholar
• Murdaca G, Orsi A, Spanò F, Puppo F, Durando P, Icardi G, Ansaldi F. Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: current views upon safety and immunogenicity. Autoimmun Rev. 2014 Feb;13(2):75–84. Epub 2013 Sep 14. PMID: 24044940. doi:10.1016/j.autrev.2013.07.007.
   PubMed Web of Science ®Google Scholar
• Vila-Córcoles A. Vaccinate your child and save its grandparents from a heart attack? Current perspectives in antipneumococcal vaccination. J Intern Med. 2009 Nov;266(5):432–44. Epub 2009 Aug 21. PMID: 19754854. doi:10.1111/j.1365-2796.2009.02149.x.
   PubMed Web of Science ®Google Scholar
• Glück T, Müller-Ladner U. Vaccination in patients with chronic rheumatic or autoimmune diseases. Clin Infect Dis. 2008 May 1;46(9):1459–65. PMID: 18419456. doi:10.1086/587063.
   PubMed Web of Science ®Google Scholar
• van Assen S, Elkayam O, Agmon-Levin N, Cervera R, Doran MF, Dougados M, Emery P, Geborek P, Ioannidis JP, Jayne DR, et al. Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League against rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases. Autoimmun Rev. 2011 Apr;10(6):341–52. Epub 2010 Dec 20. PMID: 21182987. doi:10.1016/j.autrev.2010.12.003.
   PubMed Web of Science ®Google Scholar
• Bijl M, Agmon-Levin N, Dayer JM, Israeli E, Gatto M, Shoenfeld Y. Vaccination of patients with auto-immune inflammatory rheumatic diseases requires careful benefit-risk assessment. Autoimmun Rev. 2012 Jun;11(8):572–76. Epub 2011 Oct 22. PMID: 22037116. doi:10.1016/j.autrev.2011.10.015.
   PubMed Web of Science ®Google Scholar
• Martens P, Worm SW, Lundgren B, Konradsen HB, Benfield T. Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited. BMC Infect Dis. 2004 Jun 30;4:21. PMID: 15228629; PMCID: PMC455681. doi:10.1186/1471-2334-4-21.
   PubMed Web of Science ®Google Scholar
• Murdaca G, Noberasco G, Battaglini A, Vassallo C, Giusti F, Greco M, Schiavi C, Sticchi L, Icardi G, Orsi A. Systemic sclerosis and vaccinations: a register-based cohort study about seasonal influenza and streptococcus pneumoniae vaccination rate and uptake from Liguria Regional Center, Northwest Italy. Vaccines. 2020;8:204. doi:10.3390/vaccines8020204.
   Web of Science ®Google Scholar
• Piano Nazionale Prevenzione Vaccinale (PNPV). 2017–2019. [accessed 2019 Mar 19]. www.salute.gov.it/imgs/C_17_pubblicazioni_2571_allegato.pdf.
   Google Scholar
• Harrison N, Poeppl W, Miksch M, Machold K, Kiener H, Aletaha D, Smolen J, Bahrs C, Burgmann H, Lagler H. Predictors for influenza vaccine acceptance among patients with inflammatory rheumatic diseases. Vaccine. 2018;36(32):4875–79. doi:10.1016/j.vaccine.2018.06.065.
   PubMed Web of Science ®Google Scholar
• Ministero della Salute. Vaccinazioni per categoria. [accessed 2021 Mar 22]. http://www.salute.gov.it/portale/influenza/dettaglioOpuscoliInfluenza.jsp?lingua=italiano&id=356.
   Google Scholar